← FDA Drug Approvals (Drugs@FDA)
VASOPRESSIN
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AMNEAL EU LTD · Approved 2022-08-10
Drug application
- FDA Application #
ANDA212945- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- VASOPRESSIN
- Generic name
- Vasopressin
- Active ingredients
- VASOPRESSIN
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- None (Tentative Approval)
- Sponsor
- AMNEAL EU LTD
- First approval
- 2022-08-10
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown